Distribution and prognosis of molecular breast cancer subtypes defined by immunohistochemical biomarkers in a Spanish population-based study
Montserrat Puig-Vives(Generalitat de Catalunya), Rafael Marcos‐Gragera(Generalitat de Catalunya), Josefina Perucha, Carmen Martos(Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana), Eva Ardanáz, Mónica Machón(Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública), María‐José Sánchez(Instituto de Investigación Biosanitaria de Granada), M.D. Chirlaque(Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública), Juan Mier y Díaz, J. Sánchez-Cantalejo(Andalusian School of Public Health), Antonio Navareño Mateos, A. Torrella-Ramos
Cited by 71
Related Papers
The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers
|European Journal of Cancer|2021|650
Body size and breast cancer risk: Findings from the European prospective investigation into cancer and nutrition (EPIC)
|International Journal of Cancer|2004|579
The causal link between human papillomavirus and invasive cervical cancer: A population‐based case‐control study in colombia and spain
|International Journal of Cancer|1992|576
Correction: Corrigendum: Risk Model for Colorectal Cancer in Spanish Population Using Environmental and Genetic Factors: Results from the MCC-Spain study
|Scientific Reports|2017|505
Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study
|European Journal of Cancer|2015|485